{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:58:57Z","timestamp":1789955937376,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,11]]},"DOI":"10.7759\/cureus.101316","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:04:32Z","timestamp":1768201472000},"source":"Crossref","is-referenced-by-count":1,"title":["Pathogenesis and Pharmacotherapy of Acute Respiratory Distress Syndrome Induced by Pandemic Viral Infections: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Luiza","family":"Gabunia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Khetsuriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natia","family":"Gamkrelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Gvajaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levan","family":"Ratiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gvantsa","family":"Janigashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Acute respiratory distress syndrome (ARDS): pathophysiology, management, and future perspectives","volume":"4","author":"Khan S","year":"2024","unstructured":"Khan S, Rai V, Singh S. Acute respiratory distress syndrome (ARDS): pathophysiology, management, and future perspectives. IASR J Med Pharm Sci. 2024, 4:1-3.","journal-title":"IASR J Med Pharm Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2021.05.003","article-title":"Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury","volume":"37","author":"Swenson KE","year":"2021","unstructured":"Swenson KE, Swenson ER. Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury. Crit Care Clin. 2021, 37:749-76. 10.1016\/j.ccc.2021.05.003","journal-title":"Crit Care Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri VM","year":"2012","unstructured":"Ranieri VM, Rubenfeld GD, Thompson BT, et al.. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012, 307:2526-33. 10.1001\/jama.2012.5669","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14155184","article-title":"Acute respiratory distress syndrome: pathophysiological insights, subphenotypes, and clinical implications\u2014a comprehensive review","volume":"14","author":"Ziaka M","year":"2025","unstructured":"Ziaka M, Exadaktylos A. Acute respiratory distress syndrome: pathophysiological insights, subphenotypes, and clinical implications\u2014a comprehensive review. J Clin Med. 2025, 14:5184. 10.3390\/jcm14155184","journal-title":"J Clin Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06281-2","article-title":"Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study","volume":"46","author":"Chiumello D","year":"2020","unstructured":"Chiumello D, Busana M, Coppola S, et al.. Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med. 2020, 46:2187-96. 10.1007\/s00134-020-06281-2","journal-title":"Intensive Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02127-9","article-title":"Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies","volume":"10","author":"Ma W","year":"2025","unstructured":"Ma W, Tang S, Yao P, et al.. Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies. Signal Transduct Target Ther. 2025, 10:75. 10.1038\/s41392-025-02127-9","journal-title":"Signal Transduct Target Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment","volume":"6","author":"Matthay MA","year":"2011","unstructured":"Matthay MA, Zemans RL. The acute respiratory distress syndrome: pathogenesis and treatment. Annu Rev Pathol. 2011, 6:147-63. 10.1146\/annurev-pathol-011110-130158","journal-title":"Annu Rev Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2539-x","article-title":"Influenza virus-related critical illness: pathophysiology and epidemiology","volume":"23","author":"Kalil AC","year":"2019","unstructured":"Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019, 23:258. 10.1186\/s13054-019-2539-x","journal-title":"Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107671","article-title":"Influenza virus: genomic insights, evolution, and its clinical presentation","volume":"205","author":"Jain R","year":"2025","unstructured":"Jain R, Sharma H, Pena L, Jit S, Rathi B, De Oliveira RN, Verma M. Influenza virus: genomic insights, evolution, and its clinical presentation. Microb Pathog. 2025, 205:107671. 10.1016\/j.micpath.2025.107671","journal-title":"Microb Pathog"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105738","article-title":"Influenza A virus dissemination and infection leads to tissue resident cell injury and dysfunction in viral sepsis","volume":"116","author":"Zheng Y","year":"2025","unstructured":"Zheng Y, He D, Zuo W, et al.. Influenza A virus dissemination and infection leads to tissue resident cell injury and dysfunction in viral sepsis. EBioMedicine. 2025, 116:105738. 10.1016\/j.ebiom.2025.105738","journal-title":"EBioMedicine"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.5646","article-title":"Immunogenicity and safety of influenza and COVID-19 multicomponent vaccine in adults \u226550 years: a randomized clinical trial","volume":"333","author":"Rudman Spergel AK","year":"2025","unstructured":"Rudman Spergel AK, Wu I, Deng W, et al.. Immunogenicity and safety of influenza and COVID-19 multicomponent vaccine in adults \u226550 years: a randomized clinical trial. JAMA. 2025, 333:1977-87. 10.1001\/jama.2025.5646","journal-title":"JAMA"},{"key":"ref12","unstructured":"Vaccines against influenza. WHO position paper - May 2022. https:\/\/www.who.int\/publications\/i\/item\/who-wer9719."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","unstructured":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021. a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024, 403:2133-61. 10.1016\/S0140-6736(24)00757-8","journal-title":"Lancet"},{"key":"ref14","unstructured":"Respiratory Virus Hospitalization Surveillance Network (RESP-NET). Accessed. April 8, 2025: https:\/\/www.cdc.gov\/resp-net\/dashboard\/index.html."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2021.08.018","article-title":"Long-term impact of COVID-19 associated acute respiratory distress syndrome","volume":"83","author":"Aranda J","year":"2021","unstructured":"Aranda J, Oriol I, Mart\u00edn M, et al.. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J Infect. 2021, 83:581-8. 10.1016\/j.jinf.2021.08.018","journal-title":"J Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/1040841X.2021.1960482","article-title":"The role of influenza A virus-induced hypercytokinemia","volume":"48","author":"Wei F","year":"2022","unstructured":"Wei F, Gao C, Wang Y. The role of influenza A virus-induced hypercytokinemia. Crit Rev Microbiol. 2022, 48:240-56. 10.1080\/1040841X.2021.1960482","journal-title":"Crit Rev Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2011.05.027","article-title":"Virus-induced acute respiratory distress syndrome: epidemiology, management and outcome","volume":"40","author":"Luyt C\u00c9","year":"2011","unstructured":"Luyt C\u00c9, Combes A, Trouillet JL, Nieszkowska A, Chastre J. Virus-induced acute respiratory distress syndrome: epidemiology, management and outcome. Presse Med. 2011, 40:e561-8. 10.1016\/j.lpm.2011.05.027","journal-title":"Presse Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08054-z","article-title":"The global H5N1 influenza panzootic in mammals","volume":"637","author":"Peacock TP","year":"2025","unstructured":"Peacock TP, Moncla L, Dudas G, et al.. The global H5N1 influenza panzootic in mammals. Nature. 2025, 637:304-13. 10.1038\/s41586-024-08054-z","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00283.2015","article-title":"Influenza lung injury: mechanisms and therapeutic opportunities","volume":"309","author":"Gregory DJ","year":"2015","unstructured":"Gregory DJ, Kobzik L. Influenza lung injury: mechanisms and therapeutic opportunities. Am J Physiol Lung Cell Mol Physiol. 2015, 309:L1041-6. 10.1152\/ajplung.00283.2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2011.10.002","article-title":"Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling","volume":"38","author":"Ma J","year":"2011","unstructured":"Ma J, Sun Q, Mi R, Zhang H. Avian influenza A virus H5N1 causes autophagy-mediated cell death through suppression of mTOR signaling. J Genet Genomics. 2011, 38:533-7. 10.1016\/j.jgg.2011.10.002","journal-title":"J Genet Genomics"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02542-24","article-title":"Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission","volume":"15","author":"Mostafa A","year":"2024","unstructured":"Mostafa A, Naguib MM, Nogales A, Barre RS, Stewart JP, Garc\u00eda-Sastre A, Martinez-Sobrido L. Avian influenza A (H5N1) virus in dairy cattle: origin, evolution, and cross-species transmission. mBio. 2024, 15:e0254224. 10.1128\/mbio.02542-24","journal-title":"mBio"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02209-24","article-title":"Highly pathogenic avian influenza H5N1: history, current situation, and outlook","volume":"99","author":"Krammer F","year":"2025","unstructured":"Krammer F, Hermann E, Rasmussen AL. Highly pathogenic avian influenza H5N1: history, current situation, and outlook. J Virol. 2025, 99:e0220924. 10.1128\/jvi.02209-24","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200511-1751OC","article-title":"Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice","volume":"174","author":"Xu T","year":"2006","unstructured":"Xu T, Qiao J, Zhao L, et al.. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am J Respir Crit Care Med. 2006, 174:1011-7. 10.1164\/rccm.200511-1751OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref24","unstructured":"WHO COVID-19 dashboard. Accessed. December 11, 2025: https:\/\/data.who.int\/dashboards\/covid19\/variants."},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25754","article-title":"From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and nonstructural genes","volume":"92","author":"Kandeel M","year":"2020","unstructured":"Kandeel M, Ibrahim A, Fayez M, Al-Nazawi M. From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and nonstructural genes. J Med Virol. 2020, 92:660-6. 10.1002\/jmv.25754","journal-title":"J Med Virol"},{"key":"ref26","article-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella M","year":"2025","unstructured":"Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02377-0","article-title":"Global prevalence of COVID-19-induced acute respiratory distress syndrome: systematic review and meta-analysis","volume":"12","author":"Azagew AW","year":"2023","unstructured":"Azagew AW, Beko ZW, Ferede YM, Mekonnen HS, Abate HK, Mekonnen CK. Global prevalence of COVID-19-induced acute respiratory distress syndrome: systematic review and meta-analysis. Syst Rev. 2023, 12:212. 10.1186\/s13643-023-02377-0","journal-title":"Syst Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2024.12.003","article-title":"The immunopathogenesis of a cytokine storm: the key mechanisms underlying severe COVID-19","volume":"82","author":"Hiti L","year":"2025","unstructured":"Hiti L, Markovi\u010d T, Lainscak M, Farka\u0161 Lain\u0161\u010dak J, Pal E, Mlinari\u010d-Ra\u0161\u010dan I. The immunopathogenesis of a cytokine storm: the key mechanisms underlying severe COVID-19. Cytokine Growth Factor Rev. 2025, 82:1-17. 10.1016\/j.cytogfr.2024.12.003","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000004801","article-title":"Severe influenza virus infection after COVID-19 pandemic: comparison of influenza A and influenza B","volume":"44","author":"Ak\u00e7ay N","year":"2025","unstructured":"Ak\u00e7ay N, Bing\u00f6l \u0130, Tosun D, et al.. Severe influenza virus infection after COVID-19 pandemic: comparison of influenza A and influenza B. Pediatr Infect Dis J. 2025, 44:e278-84. 10.1097\/INF.0000000000004801","journal-title":"Pediatr Infect Dis J"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.87803","article-title":"Acute respiratory distress syndrome secondary to influenza A infection in a patient with no significant risk factors: a case report","volume":"17","author":"Khouri A","year":"2025","unstructured":"Khouri A, Helou M, Haj Hussein A, Tanios A, Nakhle R. Acute respiratory distress syndrome secondary to influenza A infection in a patient with no significant risk factors: a case report. Cureus. 2025, 17:e87803. 10.7759\/cureus.87803","journal-title":"Cureus"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00679-0","article-title":"The signal pathways and treatment of cytokine storm in COVID-19","volume":"6","author":"Yang L","year":"2021","unstructured":"Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduct Target Ther. 2021, 6:255. 10.1038\/s41392-021-00679-0","journal-title":"Signal Transduct Target Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00365-9","article-title":"Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts","volume":"9","author":"Bos LD","year":"2021","unstructured":"Bos LD, Sjoding M, Sinha P, et al.. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts. Lancet Respir Med. 2021, 9:1377-86. 10.1016\/S2213-2600(21)00365-9","journal-title":"Lancet Respir Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/CNQ.0000000000000275","article-title":"Complications and outcomes of acute respiratory distress syndrome","volume":"42","author":"DiSilvio B","year":"2019","unstructured":"DiSilvio B, Young M, Gordon A, Malik K, Singh A, Cheema T. Complications and outcomes of acute respiratory distress syndrome. Crit Care Nurs Q. 2019, 42:349-61. 10.1097\/CNQ.0000000000000275","journal-title":"Crit Care Nurs Q"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.09.28","article-title":"Insights into the immuno-pathogenesis of acute respiratory distress syndrome","volume":"7","author":"Wong JJ","year":"2019","unstructured":"Wong JJ, Leong JY, Lee JH, Albani S, Yeo JG. Insights into the immuno-pathogenesis of acute respiratory distress syndrome. Ann Transl Med. 2019, 7:504. 10.21037\/atm.2019.09.28","journal-title":"Ann Transl Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-25007","article-title":"The impact of inflammatory biomarker subphenotypes on acute respiratory distress syndrome prognosis: a systematic review and meta-analysis","volume":"29","author":"Das SK","year":"2025","unstructured":"Das SK, Choupoo NS, Rochwerg B, Goswami D, Ray S, Gupta A, Kaur P. The impact of inflammatory biomarker subphenotypes on acute respiratory distress syndrome prognosis: a systematic review and meta-analysis. Indian J Crit Care Med. 2025, 29:597-603. 10.5005\/jp-journals-10071-25007","journal-title":"Indian J Crit Care Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/v17050694","article-title":"Pathogenesis induced by influenza virus infection: role of the early events of the infection and the innate immune response","volume":"17","author":"M\u00e1rquez-Bandala AH","year":"2025","unstructured":"M\u00e1rquez-Bandala AH, Gutierrez-Xicotencatl L, Esquivel-Guadarrama F. Pathogenesis induced by influenza virus infection: role of the early events of the infection and the innate immune response. Viruses. 2025, 17:694. 10.3390\/v17050694","journal-title":"Viruses"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-022-03131-3","article-title":"H5N1 infection impairs the alveolar epithelial barrier through intercellular junction proteins via Itch-mediated proteasomal degradation","volume":"5","author":"Ruan T","year":"2022","unstructured":"Ruan T, Sun Y, Zhang J, et al.. H5N1 infection impairs the alveolar epithelial barrier through intercellular junction proteins via Itch-mediated proteasomal degradation. Commun Biol. 2022, 5:186. 10.1038\/s42003-022-03131-3","journal-title":"Commun Biol"},{"key":"ref38","article-title":"Acute respiratory distress syndrome (ARDS) complicating influenza A\/H1N1v infection--a clinical approach","volume":"20","author":"Witczak A","year":"2013","unstructured":"Witczak A, Prystupa A, Kurys-Denis E, et al.. Acute respiratory distress syndrome (ARDS) complicating influenza A\/H1N1v infection--a clinical approach. Ann Agric Environ Med. 2013, 20:820-2.","journal-title":"Ann Agric Environ Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70286-X","article-title":"Pathogenesis of influenza-induced acute respiratory distress syndrome","volume":"14","author":"Short KR","year":"2014","unstructured":"Short KR, Kroeze EJ, Fouchier RA, Kuiken T. Pathogenesis of influenza-induced acute respiratory distress syndrome. Lancet Infect Dis. 2014, 14:57-69. 10.1016\/S1473-3099(13)70286-X","journal-title":"Lancet Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"Wu C","year":"2020","unstructured":"Wu C, Chen X, Cai Y, et al.. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020, 180:934-43. 10.1001\/jamainternmed.2020.0994","journal-title":"JAMA Intern Med"},{"key":"ref41","article-title":"COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management","volume":"29","author":"Ochani R","year":"2021","unstructured":"Ochani R, Asad A, Yasmin F, et al.. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management. Infez Med. 2021, 29:20-36.","journal-title":"Infez Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.930593","article-title":"Pharmacologic therapies of ARDS: from natural herb to nanomedicine","volume":"13","author":"Meng L","year":"2022","unstructured":"Meng L, Liao X, Wang Y, et al.. Pharmacologic therapies of ARDS: from natural herb to nanomedicine. Front Pharmacol. 2022, 13:930593. 10.3389\/fphar.2022.930593","journal-title":"Front Pharmacol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular complications in COVID-19","volume":"38","author":"Long B","year":"2020","unstructured":"Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020, 38:1504-7. 10.1016\/j.ajem.2020.04.048","journal-title":"Am J Emerg Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.066433","article-title":"Virus-induced acute respiratory distress syndrome causes cardiomyopathy through eliciting inflammatory responses in the heart","volume":"150","author":"Grune J","year":"2024","unstructured":"Grune J, Bajpai G, Ocak PT, et al.. Virus-induced acute respiratory distress syndrome causes cardiomyopathy through eliciting inflammatory responses in the heart. Circulation. 2024, 150:49-61. 10.1161\/CIRCULATIONAHA.123.066433","journal-title":"Circulation"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202311-2011ST","article-title":"An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society clinical practice guideline","volume":"209","author":"Qadir N","year":"2024","unstructured":"Qadir N, Sahetya S, Munshi L, et al.. An update on management of adult patients with acute respiratory distress syndrome: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2024, 209:24-36. 10.1164\/rccm.202311-2011ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar J","year":"2020","unstructured":"Villar J, Ferrando C, Mart\u00ednez D, et al.. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020, 8:267-76. 10.1016\/S2213-2600(19)30417-5","journal-title":"Lancet Respir Med"},{"key":"ref47","article-title":"Acute respiratory distress syndrome","author":"Diamond M","year":"2025","unstructured":"Diamond M, Peniston HL, Sanghavi DK, Mahapatra S. Acute respiratory distress syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073649","article-title":"Repurposing multiple-molecule drugs for COVID-19-associated acute respiratory distress syndrome and non-viral acute respiratory distress syndrome via a systems biology approach and a DNN-DTI model based on five drug design specifications","volume":"23","author":"Ting CT","year":"2022","unstructured":"Ting CT, Chen BS. Repurposing multiple-molecule drugs for COVID-19-associated acute respiratory distress syndrome and non-viral acute respiratory distress syndrome via a systems biology approach and a DNN-DTI model based on five drug design specifications. Int J Mol Sci. 2022, 23:3649. 10.3390\/ijms23073649","journal-title":"Int J Mol Sci"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-020-00532-2","article-title":"Recent developments on therapeutic and diagnostic approaches for COVID-19","volume":"23","author":"Majumder J","year":"2021","unstructured":"Majumder J, Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 2021, 23:14. 10.1208\/s12248-020-00532-2","journal-title":"AAPS J"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-020-0642-4","article-title":"Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study","volume":"10","author":"Tsai MJ","year":"2020","unstructured":"Tsai MJ, Yang KY, Chan MC, et al.. Impact of corticosteroid treatment on clinical outcomes of influenza-associated ARDS: a nationwide multicenter study. Ann Intensive Care. 2020, 10:26. 10.1186\/s13613-020-0642-4","journal-title":"Ann Intensive Care"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59732-7","article-title":"Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis","volume":"10","author":"Zhou Y","year":"2020","unstructured":"Zhou Y, Fu X, Liu X, et al.. Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis. Sci Rep. 2020, 10:3044. 10.1038\/s41598-020-59732-7","journal-title":"Sci Rep"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201101-0135OC","article-title":"Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome","volume":"183","author":"Brun-Buisson C","year":"2011","unstructured":"Brun-Buisson C, Richard JC, Mercat A, Thi\u00e9baut AC, Brochard L. Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011, 183:1200-6. 10.1164\/rccm.201101-0135OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-009-1727-6","article-title":"H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment","volume":"36","author":"Quispe-Laime AM","year":"2010","unstructured":"Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, Meduri GU. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med. 2010, 36:33-41. 10.1007\/s00134-009-1727-6","journal-title":"Intensive Care Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID- 19: the CoDEX randomized clinical trial","volume":"324","author":"Tomazini BM","year":"2020","unstructured":"Tomazini BM, Maia IS, Cavalcanti AB, et al.. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID- 19: the CoDEX randomized clinical trial. JAMA. 2020, 324:1307-16. 10.1001\/jama.2020.17021","journal-title":"JAMA"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2381086","article-title":"Efficacy of corticosteroids in patients with acute respiratory distress syndrome: a meta-analysis","volume":"56","author":"Li G","year":"2024","unstructured":"Li G, Chen D, Gao F, et al.. Efficacy of corticosteroids in patients with acute respiratory distress syndrome: a meta-analysis. Ann Med. 2024, 56:2381086. 10.1080\/07853890.2024.2381086","journal-title":"Ann Med"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06394-2","article-title":"Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis","volume":"47","author":"Chaudhuri D","year":"2021","unstructured":"Chaudhuri D, Sasaki K, Karkar A, et al.. Corticosteroids in COVID-19 and non-COVID-19 ARDS: a systematic review and meta-analysis. Intensive Care Med. 2021, 47:521-37. 10.1007\/s00134-021-06394-2","journal-title":"Intensive Care Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001525","article-title":"Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses\u2014a systematic review","volume":"10","author":"Ragel EJ","year":"2023","unstructured":"Ragel EJ, Harris LK, Campbell RA. Acute respiratory distress syndrome: potential of therapeutic interventions effective in treating progression from COVID-19 to treat progression from other illnesses\u2014a systematic review. BMJ Open Respir Res. 2023, 10:10.1136\/bmjresp-2022-001525","journal-title":"BMJ Open Respir Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04516-4","article-title":"Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial","volume":"27","author":"Atmowihardjo LN","year":"2023","unstructured":"Atmowihardjo LN, Schippers JR, Duijvelaar E, et al.. Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial. Crit Care. 2023, 27:226. 10.1186\/s13054-023-04516-4","journal-title":"Crit Care"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1177\/08850666211066799","article-title":"High- versus low-dose dexamethasone for the treatment of COVID-19-related acute respiratory distress syndrome: a multicenter, randomized open-label clinical trial","volume":"37","author":"Maskin LP","year":"2022","unstructured":"Maskin LP, Bonelli I, Olarte GL, et al.. High- versus low-dose dexamethasone for the treatment of COVID-19-related acute respiratory distress syndrome: a multicenter, randomized open-label clinical trial. J Intensive Care Med. 2022, 37:491-9. 10.1177\/08850666211066799","journal-title":"J Intensive Care Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-02215-6","article-title":"Effects of two different dexamethasone dosing regimens on ventilator-free days and long-term mortality in COVID-19 patients with moderate-to-severe ARDS: the REMED randomized clinical trial","volume":"29","author":"Mal\u00e1ska J","year":"2024","unstructured":"Mal\u00e1ska J, Sta\u0161ek J, M\u00e1ca J, et al.. Effects of two different dexamethasone dosing regimens on ventilator-free days and long-term mortality in COVID-19 patients with moderate-to-severe ARDS: the REMED randomized clinical trial. Eur J Med Res. 2024, 29:616. 10.1186\/s40001-024-02215-6","journal-title":"Eur J Med Res"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5332-4","article-title":"Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study","volume":"44","author":"Moreno G","year":"2018","unstructured":"Moreno G, Rodr\u00edguez A, Reyes LF, et al.. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Med. 2018, 44:1470-82. 10.1007\/s00134-018-5332-4","journal-title":"Intensive Care Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/aas.14346","article-title":"Dexamethasone doses in patients with COVID-19 and hypoxia: a systematic review and meta-analysis","volume":"68","author":"Munch MW","year":"2024","unstructured":"Munch MW, Granholm A, Mal\u00e1ska J, et al.. Dexamethasone doses in patients with COVID-19 and hypoxia: a systematic review and meta-analysis. Acta Anaesthesiol Scand. 2024, 68:146-66. 10.1111\/aas.14346","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-052422-020316","article-title":"Treatments for COVID-19","volume":"75","author":"Andrews HS","year":"2024","unstructured":"Andrews HS, Herman JD, Gandhi RT. Treatments for COVID-19. Annu Rev Med. 2024, 75:145-57. 10.1146\/annurev-med-052422-020316","journal-title":"Annu Rev Med"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2024.12.002","article-title":"Immunobiology and immunotherapy of COVID-19","volume":"213","author":"Lundstrom K","year":"2025","unstructured":"Lundstrom K. Immunobiology and immunotherapy of COVID-19. Prog Mol Biol Transl Sci. 2025, 213:73-133. 10.1016\/bs.pmbts.2024.12.002","journal-title":"Prog Mol Biol Transl Sci"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-025-05291-0","article-title":"A narrative review on the future of ARDS: evolving definitions, pathophysiology, and tailored management","volume":"29","author":"Al-Husinat L","year":"2025","unstructured":"Al-Husinat L, Azzam S, Al Sharie S, et al.. A narrative review on the future of ARDS: evolving definitions, pathophysiology, and tailored management. Crit Care. 2025, 29:88. 10.1186\/s13054-025-05291-0","journal-title":"Crit Care"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-023-00333-2","article-title":"Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance","volume":"20","author":"Scaramuzzo G","year":"2023","unstructured":"Scaramuzzo G, Nucera F, Asmundo A, et al.. Cellular and molecular features of COVID-19 associated ARDS: therapeutic relevance. J Inflamm (Lond). 2023, 20:11. 10.1186\/s12950-023-00333-2","journal-title":"J Inflamm (Lond)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450833-pathogenesis-and-pharmacotherapy-of-acute-respiratory-distress-syndrome-induced-by-pandemic-viral-infections-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T07:04:35Z","timestamp":1768201475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450833-pathogenesis-and-pharmacotherapy-of-acute-respiratory-distress-syndrome-induced-by-pandemic-viral-infections-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":66,"URL":"https:\/\/doi.org\/10.7759\/cureus.101316","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,11]]}}}